4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-23-093073
President and CEO acquired 800,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bashan Dror President and CEO | 2023-08-15 | Grant or award | +800,000 | 1,885,458 | I |
Loading xslF345X05/tm2324046-4_4seq1.xml…